Our in-silico pathway enrichment analysis showed that the set of six circulating miRNAs targets brain-specific genes involved in early AD pathological processes, including apoptosis and TLR and NF-κβ inflammatory signalling pathways. The gene discussed is NFKB1; the disease is Alzheimer disease.